MAM
MPM Asset Management Portfolio holdings
AUM
$43.3M
This Quarter Return
+8.83%
1 Year Return
-54.44%
3 Year Return
+14.05%
5 Year Return
-29.8%
10 Year Return
-11.6%
AUM
$308M
AUM Growth
+$308M
(-4.5%)
Cap. Flow
-$7.79M
Cap. Flow
% of AUM
-2.53%
Top 10 Holdings %
Top 10 Hldgs %
99.87%
Holding
15
New
–
Increased
2
Reduced
1
Closed
1
Top Buys
| 1 |
CHMA
Chiasma, Inc. Common Stock
CHMA
|
$158K |
Top Sells
| 1 |
NVRO
NEVRO CORP.
NVRO
|
$5.72M |
| 2 |
Avalo Therapeutics
AVTX
|
$2.22M |
Sector Composition
| 1 | Healthcare | 23.66% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
RDUS
1
DELISTED
Radius Health, Inc.
RDUS
| $214M | 69.51% | 5,831,253 | – | – |
|
2
Syndax Pharmaceuticals
SNDX
$1.41B
| $21.4M | 6.93% | 2,168,691 | – | – |
|
|
EPZM
3
DELISTED
Epizyme, Inc
EPZM
| $17.7M | 5.75% | 1,729,674 | – | – |
|
|
CHMA
4
DELISTED
Chiasma, Inc. Common Stock
CHMA
| $16.6M | 5.38% | 5,736,296 +54,752 | +1% | +$158K |
|
|
ELGX
5
DELISTED
Endologix Inc
ELGX
| $14M | 4.53% | 1,121,447 | – | – |
|
6
Protara Therapeutics
TARA
$120M
| $7.9M | 2.56% | 983,381 | – | – |
|
|
PETX
7
DELISTED
Aratana Therapeutics, Inc.
PETX
| $7.07M | 2.29% | 1,117,875 | – | – |
|
|
NVRO
8
DELISTED
NEVRO CORP.
NVRO
| $5.34M | 1.73% | 72,413 -77,587 | -52% | -$5.72M |
|
|
HSTO
9
DELISTED
Histogen Inc. Common Stock
HSTO
| $2.46M | 0.8% | 1,192,080 | – | – |
|
10
Savara
SVRA
$567M
| $1.2M | 0.39% | 2,551,851 | – | – |
|
|
CLCD
11
DELISTED
CoLucid Pharmaceuticals, Inc.
CLCD
| $178K | 0.06% | 21,806 | – | – |
|
12
Sangamo Therapeutics
SGMO
$157M
| $130K | 0.04% | 22,487 | – | – |
|
13
MacroGenics
MGNX
$112M
| $86K | 0.03% | 3,168 | – | – |
|
|
14
Avalo Therapeutics
AVTX
$122M
| – | – | -595,436 | Closed | -$2.22M |
|